Trademark Overview
On Thursday, June 12, 2025, a trademark application was filed for NUCLEOPORATION with the United States Patent and Trademark Office. The USPTO has given the NUCLEOPORATION trademark a serial number of 99232267. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 12, 2025. The NUCLEOPORATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Biotechnology research; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Biotechnology research in the field of Cell Therapies, Gene Therapies, Cancer Therapies, Cardiovascular Therapies, Genetic and Metabolic Therapies, Gene Editing, Hematologic and Immunologic Therapies, Infectious Diseases Therapies, Rare Diseases Therapies, Musculoskeletal Therapies, Neurologic and Ophthalmic Therapies, Non-Viral Therapeutic Delivery, Prenatal Therapies, Respiratory and Gastrointestinal Therapies, Stem Cell Therapies,; Development of new technology for others in the field of Drug Delivery Mechanisms, Biotechnology and Pharmaceutical Drug Development
